A culture system that identifies the precursor of murine bone marrow fibroblastic stromal cells (stroma-initiating cells, SIC) has been developed. In this system, mature fibroblasts are depleted by adherence to plastic dishes and the nonadherent cells are seeded at a low density, which results in th
The effect of rhGM-CSF on the proliferation of osteogenic sarcoma cells
✍ Scribed by Dr. W. Jeffrey Baker; Jeffrey B. Hargis; Romano Danesi; Renato V. La Rocca
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 400 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Recombinant human granulocyte–macrophage colony‐stimulating factor (rhGM‐CSF) promotes the growth of a variety of hematopoietic and nonhematopoietic cells, both benign and malignant. There is now evidence that osteoblast‐like cells produce GM‐CSF and their growth is stimulated by this cytokine in vitro. We have studied the effect of rhGM‐CSF on DNA synthesis and cell proliferation in the human osteogenic sarcoma cell lines U‐20S, G‐292, MG‐63, and HOS. RhGM‐CSF stimulated a dose‐dependent increase in radioactive thymidine incorporation in each of the four cell lines in the presence of serum‐free media, and in two cell lines (HOS and U‐20S) in the presence of fetal bovine serum (FBS). In addition, rhGM‐CSF produced significant increases in cell proliferation in two cell lines (MG‐63 and U‐20S) in the presence of 2% FBS. These results suggest that GM‐CSF may have an important role in the biology of human osteogenic sarcoma cells. The clinical implications of these findings merit further investigation.
📜 SIMILAR VOLUMES
## Background: To determine if hypoxia stimulates the proliferation of retinal microvessel endothelial cells in culture. Methods: Bovine retinal microvessel endothelial cells were cultured in normoxic (95% air, 5% CO 2 ) and hypoxic (2% O 2 , 5% CO 2 , 93% N 2 ) conditions. Endothelial cells were
Previously we reported the amplification of the peripheral myelin protein 22 (PMP22) gene in cell lines of human osteogenic and glioma tumors. PMP22 normally is expressed at high levels in Schwann cells of the peripheral nervous system and is suggested to function as a structural protein of the myel